O	O	0	5	Thiol	Thiol	B-NP	NN	O	2	NMOD	O
O	O	6	16	modulation	modulation	I-NP	NN	O	3	SUB	O
O	O	17	25	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	O
O	O	26	29	the	the	B-NP	DT	O	7	NMOD	O
O	O	30	41	interleukin	interleukin	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	42	43	(	(	O	(	I-protein	7	NMOD	I-protein
O	O	43	45	IL	IL	B-NP	NN	I-protein	13	NMOD	I-protein
O	O	45	46	)	)	O	)	I-protein	7	NMOD	I-protein
O	O	46	47	-	-	B-NP	HYPH	I-protein	7	NMOD	I-protein
O	O	47	48	1	1	I-NP	CD	I-protein	7	NMOD	I-protein
O	O	48	49	-	-	I-NP	HYPH	I-protein	7	P	I-protein
O	O	49	57	mediated	mediate	I-NP	VBN	O	13	NMOD	O
O	O	58	68	activation	activation	I-NP	NN	O	3	OBJ	O
O	O	69	71	of	of	B-PP	IN	O	13	NMOD	O
O	O	72	74	an	an	B-NP	DT	O	19	NMOD	O
T1	B-Protein	75	77	IL	IL	I-NP	NN	B-protein	19	NMOD	B-protein
T1	I-Protein	77	78	-	-	B-NP	HYPH	I-protein	19	P	I-protein
T1	I-Protein	78	79	1	1	I-NP	CD	I-protein	19	NMOD	I-protein
T1	I-Protein	80	88	receptor	receptor	I-NP	NN	I-protein	14	PMOD	I-protein
O	O	88	89	-	-	B-PP	HYPH	O	3	P	O
O	O	89	99	associated	associate	B-NP	VBN	O	28	NMOD	O
O	O	100	107	protein	protein	I-NP	NN	O	23	NMOD	O
O	O	108	114	kinase	kinase	I-NP	NN	O	28	NMOD	O
O	O	115	118	and	and	I-NP	CC	O	28	NMOD	O
T9	B-Entity	119	121	NF	NF	I-NP	NN	B-protein	28	NMOD	B-protein
T9	I-Entity	121	122	-	-	B-NP	HYPH	I-protein	28	NMOD	I-protein
T9	I-Entity	122	127	kappa	kappa	I-NP	NN	I-protein	28	NMOD	I-protein
T9	I-Entity	128	129	B	B	I-NP	NN	I-protein	3	VMOD	I-protein
O	O	129	130	.	.	O	.	O	3	P	O

O	O	132	135	The	The	B-NP	DT	O	13	VMOD	O
T2	B-Protein	136	147	interleukin	interleukin	I-NP	NN	B-protein	13	SUB	B-protein
T2	I-Protein	147	148	-	-	B-NP	HYPH	O	2	NMOD	O
T2	I-Protein	148	149	1	1	I-NP	CD	O	3	NMOD	O
T2	I-Protein	150	158	receptor	receptor	I-NP	NN	O	6	NMOD	O
T2	I-Protein	159	163	type	type	I-NP	NN	O	4	NMOD	O
T2	I-Protein	164	165	I	I	I-NP	CD	O	6	NMOD	O
O	O	166	167	(	(	O	(	O	12	DEP	O
T3	B-Protein	167	169	IL	IL	B-NP	NN	B-protein	11	NMOD	B-protein
T3	I-Protein	169	170	-	-	B-NP	HYPH	I-protein	11	P	I-protein
T3	I-Protein	170	173	1RI	1RI	I-NP	NN	I-protein	12	DEP	I-protein
O	O	173	174	)	)	O	)	O	6	NMOD	O
O	O	175	177	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	178	188	associated	associate	I-VP	VBN	O	13	VC	O
O	O	189	193	with	with	B-PP	IN	O	14	VMOD	O
O	O	194	199	other	other	B-NP	JJ	O	17	NMOD	O
O	O	200	208	proteins	protein	I-NP	NNS	O	15	PMOD	O
O	O	209	213	thus	thus	B-VP	RB	O	19	VMOD	O
O	O	214	221	forming	form	I-VP	VBG	O	17	NMOD	O
O	O	222	223	a	a	B-NP	DT	O	22	NMOD	O
T10	B-Entity	224	231	complex	complex	I-NP	JJ	O	22	NMOD	O
T10	I-Entity	232	238	system	system	I-NP	NN	O	19	OBJ	O
O	O	239	241	by	by	B-PP	IN	O	22	NMOD	O
O	O	242	247	which	which	B-NP	WDT	O	23	PMOD	O
O	O	248	250	IL	IL	B-VP	NN	B-protein	26	NMOD	B-protein
O	O	250	251	-	-	B-NP	HYPH	I-protein	28	SUB	I-protein
O	O	251	252	1	1	I-NP	CD	I-protein	26	NMOD	I-protein
O	O	253	259	exerts	exert	B-VP	VBZ	O	23	SBAR	O
O	O	260	263	its	its	B-NP	PRP$	O	31	NMOD	O
O	O	264	271	various	various	I-NP	JJ	O	31	NMOD	O
O	O	272	279	signals	signal	I-NP	NNS	O	28	OBJ	O
O	O	279	280	.	.	O	.	O	13	P	O

O	O	281	284	The	The	B-NP	DT	O	3	NMOD	O
O	O	285	295	initiating	initiate	I-NP	VBG	O	3	NMOD	O
O	O	296	301	event	event	I-NP	NN	O	4	SUB	O
O	O	302	304	is	be	B-VP	VBZ	O	19	VMOD	O
O	O	305	310	still	still	B-ADVP	RB	O	4	VMOD	O
O	O	311	320	uncertain	uncertain	B-ADJP	JJ	O	4	PRD	O
O	O	320	321	,	,	O	,	O	19	P	O
O	O	322	325	but	but	O	CC	O	19	VMOD	O
O	O	326	336	activation	activation	B-NP	NN	O	19	SUB	O
O	O	337	339	of	of	B-PP	IN	O	9	NMOD	O
O	O	340	341	a	a	B-NP	DT	O	18	NMOD	O
O	O	342	350	recently	recently	I-NP	RB	O	13	AMOD	O
O	O	351	360	described	describe	I-NP	VBN	O	18	NMOD	O
O	O	361	369	receptor	receptor	I-NP	NN	B-protein	18	NMOD	B-protein
O	O	369	370	-	-	B-VP	HYPH	I-protein	18	NMOD	I-protein
O	O	370	380	associated	associate	B-NP	VBN	I-protein	18	NMOD	I-protein
O	O	381	388	protein	protein	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	389	395	kinase	kinase	I-NP	NN	I-protein	10	PMOD	I-protein
O	O	396	398	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	399	402	one	one	B-NP	CD	O	19	PRD	O
O	O	403	405	of	of	B-PP	IN	O	20	NMOD	O
O	O	406	409	the	the	B-NP	DT	O	24	NMOD	O
O	O	410	418	earliest	early	I-NP	JJS	O	24	NMOD	O
O	O	419	425	events	event	I-NP	NNS	O	21	PMOD	O
O	O	426	436	detectable	detectable	B-ADJP	JJ	O	24	NMOD	O
O	O	437	438	(	(	O	(	O	43	DEP	O
O	O	438	444	Martin	Martin	B-NP	NNP	O	30	NMOD	O
O	O	445	447	et	et	I-NP	FW	O	30	NMOD	O
O	O	448	450	al	al	I-NP	FW	O	30	NMOD	O
O	O	450	451	.	.	I-NP	FW	O	42	NMOD	O
O	O	451	452	,	,	O	,	O	42	P	O
O	O	453	456	Eur	Eur	B-NP	NNP	O	34	NMOD	O
O	O	456	457	.	.	I-NP	.	O	34	P	O
O	O	457	458	J	J	I-NP	NNP	O	42	NMOD	O
O	O	458	459	.	.	I-NP	.	O	42	NMOD	O
O	O	459	466	Immunol	Immunol	I-NP	NNP	O	42	NMOD	O
O	O	466	467	.	.	I-NP	.	O	42	P	O
O	O	467	471	1994	1994	I-NP	CD	O	42	NMOD	O
O	O	471	472	.	.	I-NP	.	O	38	P	O
O	O	472	474	24	24	I-NP	CD	O	42	NMOD	O
O	O	474	475	:	:	O	:	O	42	P	O
O	O	476	480	1566	1566	B-NP	CD	O	43	DEP	O
O	O	480	481	)	)	O	)	O	19	VMOD	O
O	O	481	482	.	.	O	.	O	19	P	O

O	O	483	485	IL	IL	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	485	486	-	-	B-NP	HYPH	I-protein	1	P	I-protein
O	O	486	487	1	1	I-NP	CD	I-protein	1	NMOD	I-protein
O	O	488	497	signaling	signaling	I-NP	NN	O	5	SUB	O
O	O	498	500	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	501	509	commonly	commonly	I-VP	RB	O	5	VMOD	O
O	O	510	521	accompanied	accompany	I-VP	VBN	O	5	VC	O
O	O	522	524	by	by	B-PP	IN	O	7	VMOD	O
O	O	525	534	oxidative	oxidative	B-NP	JJ	O	10	NMOD	O
O	O	535	544	processes	process	I-NP	NNS	O	8	PMOD	O
O	O	545	548	and	and	O	CC	O	5	VMOD	O
O	O	549	551	is	be	B-VP	VBZ	O	5	VMOD	O
O	O	552	559	thought	think	I-VP	VBN	O	12	VC	O
O	O	560	562	to	to	I-VP	TO	O	15	VMOD	O
O	O	563	565	be	be	I-VP	VB	O	13	VMOD	O
O	O	566	573	subject	subject	B-ADJP	JJ	O	15	PRD	O
O	O	574	576	to	to	B-PP	TO	O	16	AMOD	O
O	O	577	582	redox	redox	B-NP	NN	O	19	NMOD	O
O	O	583	593	regulation	regulation	I-NP	NN	O	17	PMOD	O
O	O	593	594	.	.	O	.	O	5	P	O

O	O	595	597	We	We	B-NP	PRP	O	3	SUB	O
O	O	598	607	therefore	therefore	B-ADVP	RB	O	3	VMOD	O
O	O	608	620	investigated	investigate	B-VP	VBD	O	0	ROOT	O
O	O	621	628	whether	whether	B-SBAR	IN	O	24	DEP	O
O	O	629	632	the	the	B-NP	DT	O	6	NMOD	O
O	O	633	643	activation	activation	I-NP	NN	O	16	SUB	O
O	O	644	646	of	of	B-PP	IN	O	6	NMOD	O
O	O	647	650	the	the	B-NP	DT	O	15	NMOD	O
T4	B-Protein	651	653	IL	IL	I-NP	NN	B-protein	15	NMOD	B-protein
T4	I-Protein	653	654	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T4	I-Protein	654	657	1RI	1RI	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	657	658	-	-	O	HYPH	I-protein	15	NMOD	I-protein
O	O	658	668	associated	associate	B-NP	VBN	I-protein	15	NMOD	I-protein
O	O	669	676	protein	protein	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	677	683	kinase	kinase	I-NP	NN	I-protein	7	PMOD	I-protein
O	O	684	689	could	could	B-VP	MD	O	4	SBAR	O
O	O	690	692	be	be	I-VP	VB	O	16	VC	O
O	O	693	694	a	a	B-NP	DT	O	19	NMOD	O
O	O	695	701	target	target	I-NP	NN	O	17	PRD	O
O	O	702	705	for	for	B-PP	IN	O	19	NMOD	O
O	O	706	711	redox	redox	B-NP	NN	O	22	NMOD	O
O	O	712	722	regulation	regulation	I-NP	NN	O	20	PMOD	O
O	O	723	726	and	and	B-PP	CC	O	24	DEP	O
O	O	727	734	whether	whether	B-SBAR	IN	O	3	VMOD	O
O	O	735	737	an	an	B-NP	DT	O	27	NMOD	O
O	O	738	745	altered	altered	I-NP	JJ	O	27	NMOD	O
O	O	746	754	activity	activity	I-NP	NN	O	31	SUB	O
O	O	755	757	of	of	B-PP	IN	O	27	NMOD	O
O	O	758	761	the	the	B-NP	DT	O	30	NMOD	O
O	O	762	768	kinase	kinase	I-NP	NN	B-protein	28	PMOD	B-protein
O	O	769	774	could	could	B-VP	MD	O	24	SBAR	O
O	O	775	784	influence	influence	I-VP	VB	O	31	VC	O
O	O	785	787	IL	IL	B-NP	NN	B-protein	34	NMOD	B-protein
O	O	787	788	-	-	B-NP	HYPH	I-protein	37	P	I-protein
O	O	788	789	1	1	I-NP	CD	I-protein	34	NMOD	I-protein
O	O	789	790	-	-	I-NP	HYPH	O	34	P	O
O	O	790	798	mediated	mediate	I-NP	VBN	O	42	NMOD	O
T11	B-Entity	799	801	NF	NF	I-NP	NN	B-protein	42	NMOD	B-protein
T11	I-Entity	801	802	-	-	B-NP	HYPH	I-protein	42	NMOD	I-protein
T11	I-Entity	802	807	kappa	kappa	I-NP	NN	I-protein	42	NMOD	I-protein
T11	I-Entity	808	809	B	B	I-NP	NN	I-protein	42	NMOD	I-protein
O	O	810	820	activation	activation	I-NP	NN	O	32	OBJ	O
O	O	820	821	.	.	O	.	O	3	P	O

O	O	822	823	A	A	B-NP	DT	O	5	NMOD	O
O	O	824	830	murine	murine	I-NP	JJ	B-cell_line	5	NMOD	B-cell_line
O	O	831	832	T	T	I-NP	NN	I-cell_line	5	NMOD	I-cell_line
O	O	833	837	cell	cell	I-NP	NN	I-cell_line	5	NMOD	I-cell_line
O	O	838	842	line	line	I-NP	NN	I-cell_line	7	NMOD	I-cell_line
O	O	842	843	,	,	O	,	O	7	P	O
O	O	844	847	EL4	EL4	B-NP	NN	B-cell_line	9	SUB	B-cell_line
O	O	847	848	,	,	O	,	O	7	P	O
O	O	849	852	was	be	B-VP	VBD	O	0	ROOT	O
O	O	853	863	stimulated	stimulate	I-VP	VBN	O	9	VC	O
O	O	864	868	with	with	B-PP	IN	O	10	VMOD	O
O	O	869	871	IL	IL	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	871	872	-	-	B-NP	HYPH	I-protein	11	PMOD	I-protein
O	O	872	873	1	1	I-NP	CD	I-protein	13	NMOD	I-protein
O	O	874	878	with	with	B-PP	IN	O	10	VMOD	O
O	O	879	882	and	and	I-PP	CC	O	15	PMOD	O
O	O	883	890	without	without	I-PP	IN	O	15	PMOD	O
O	O	891	903	pretreatment	pretreatment	B-NP	NN	O	15	PMOD	O
O	O	904	908	with	with	B-PP	IN	O	15	PMOD	O
O	O	909	918	different	different	B-NP	JJ	O	21	NMOD	O
O	O	919	928	compounds	compound	I-NP	NNS	O	19	PMOD	O
O	O	929	934	known	know	B-VP	VBN	O	21	NMOD	O
O	O	935	937	to	to	I-VP	TO	O	24	VMOD	O
O	O	938	947	influence	influence	I-VP	VB	O	22	VMOD	O
O	O	948	951	the	the	B-NP	DT	O	28	NMOD	O
O	O	952	960	cellular	cellular	I-NP	JJ	O	28	NMOD	O
O	O	961	966	redox	redox	I-NP	NN	O	28	NMOD	O
O	O	967	973	status	status	I-NP	NN	O	24	OBJ	O
O	O	973	974	.	.	O	.	O	9	P	O

O	O	975	980	Thiol	Thiol	B-NP	NN	O	3	NMOD	O
O	O	981	990	modifying	modify	B-VP	VBG	O	3	NMOD	O
O	O	991	997	agents	agent	B-NP	NNS	O	20	SUB	O
O	O	998	1002	like	like	B-PP	IN	O	3	NMOD	O
O	O	1003	1010	diamide	diamide	B-NP	NN	O	19	NMOD	O
O	O	1010	1011	,	,	O	,	O	19	P	O
O	O	1012	1021	menadione	menadione	B-NP	NN	O	19	NMOD	O
O	O	1021	1022	,	,	O	,	O	19	P	O
O	O	1023	1034	pyrrolidine	pyrrolidine	B-NP	NN	O	10	NMOD	O
O	O	1035	1050	dithiocarbamate	dithiocarbamate	I-NP	NN	O	19	NMOD	O
O	O	1051	1052	(	(	O	(	O	13	DEP	O
O	O	1052	1056	PDTC	PDTC	B-NP	NN	O	13	DEP	O
O	O	1056	1057	)	)	O	)	O	10	NMOD	O
O	O	1057	1058	,	,	O	,	O	19	P	O
O	O	1059	1066	diethyl	diethyl	B-NP	NN	O	16	NMOD	O
O	O	1067	1082	dithiocarbamate	dithiocarbamate	I-NP	NN	O	19	NMOD	O
O	O	1083	1085	or	or	O	CC	O	19	NMOD	O
O	O	1086	1098	phenylarsine	phenylarsine	B-NP	NN	O	19	NMOD	O
O	O	1099	1104	oxide	oxide	I-NP	NN	O	4	PMOD	O
O	O	1105	1114	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
O	O	1115	1118	the	the	B-NP	DT	O	27	NMOD	O
O	O	1119	1121	IL	IL	I-NP	NN	B-protein	23	NMOD	B-protein
O	O	1121	1122	-	-	B-NP	HYPH	I-protein	27	NMOD	I-protein
O	O	1122	1123	1	1	I-NP	CD	I-protein	23	NMOD	I-protein
O	O	1123	1124	-	-	B-NP	HYPH	O	23	P	O
O	O	1124	1131	induced	induce	I-NP	VBN	O	27	NMOD	O
O	O	1132	1142	activation	activation	I-NP	NN	O	20	OBJ	O
O	O	1143	1145	of	of	B-PP	IN	O	27	NMOD	O
O	O	1146	1149	the	the	B-NP	DT	O	36	NMOD	O
T5	B-Protein	1150	1152	IL	IL	I-NP	NN	B-protein	36	NMOD	B-protein
T5	I-Protein	1152	1153	-	-	B-NP	HYPH	I-protein	36	NMOD	I-protein
T5	I-Protein	1153	1156	1RI	1RI	I-NP	NN	I-protein	36	NMOD	I-protein
O	O	1156	1157	-	-	O	HYPH	I-protein	36	NMOD	I-protein
O	O	1157	1167	associated	associate	B-NP	VBN	I-protein	36	NMOD	I-protein
O	O	1168	1175	protein	protein	I-NP	NN	I-protein	36	NMOD	I-protein
O	O	1176	1182	kinase	kinase	I-NP	NN	I-protein	28	PMOD	I-protein
O	O	1182	1183	.	.	O	.	O	20	P	O

T12	B-Entity	1184	1185	N	N	B-NP	NN	O	15	SUB	O
T12	I-Entity	1185	1186	-	-	O	HYPH	O	15	P	O
T12	I-Entity	1186	1200	Acetylcysteine	Acetylcysteine	B-NP	NN	O	14	NMOD	O
O	O	1200	1201	,	,	O	,	O	14	P	O
O	O	1202	1207	alpha	alpha	B-NP	NN	O	14	NMOD	O
O	O	1207	1208	,	,	O	,	O	14	P	O
O	O	1208	1213	alpha	alpha	B-NP	SYM	O	14	NMOD	O
O	O	1213	1214	'	'	I-NP	SYM	O	14	NMOD	O
O	O	1214	1215	-	-	I-NP	HYPH	O	14	NMOD	O
O	O	1215	1224	dipyridyl	dipyridyl	I-NP	NN	O	14	NMOD	O
O	O	1224	1225	,	,	I-NP	,	O	14	P	O
O	O	1226	1239	aminotriazole	aminotriazole	I-NP	NN	O	14	NMOD	O
O	O	1240	1242	or	or	I-NP	CC	O	14	NMOD	O
O	O	1243	1257	nitrofurantoin	nitrofurantoin	I-NP	NN	O	15	SUB	O
O	O	1258	1261	did	do	B-VP	VBD	O	0	ROOT	O
O	O	1262	1265	not	not	I-VP	RB	O	15	VMOD	O
O	O	1266	1270	show	show	I-VP	VB	O	15	VC	O
O	O	1271	1274	any	any	B-NP	DT	O	19	NMOD	O
O	O	1275	1281	effect	effect	I-NP	NN	O	17	OBJ	O
O	O	1281	1282	.	.	O	.	O	15	P	O

O	O	1283	1286	The	The	B-NP	DT	O	2	NMOD	O
O	O	1287	1297	inhibition	inhibition	I-NP	NN	O	5	SUB	O
O	O	1298	1300	by	by	B-PP	IN	O	2	NMOD	O
O	O	1301	1305	PDTC	PDTC	B-NP	NN	O	3	PMOD	O
O	O	1306	1309	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1310	1320	reversible	reversible	B-ADJP	JJ	O	5	PRD	O
O	O	1321	1327	unless	unless	B-SBAR	IN	O	5	VMOD	O
T13	B-Entity	1328	1339	glutathione	glutathione	B-NP	NN	O	9	NMOD	O
O	O	1340	1349	synthesis	synthesis	I-NP	NN	O	10	SUB	O
O	O	1350	1353	was	be	B-VP	VBD	O	7	SBAR	O
O	O	1354	1361	blocked	block	I-VP	VBN	O	10	VC	O
O	O	1362	1364	by	by	B-PP	IN	O	11	VMOD	O
O	O	1365	1375	buthionine	buthionine	B-NP	NN	O	14	NMOD	O
O	O	1376	1387	sulfoximine	sulfoximine	I-NP	NN	O	12	PMOD	O
O	O	1387	1388	.	.	O	.	O	5	P	O

O	O	1389	1392	The	The	B-NP	DT	O	3	NMOD	O
O	O	1393	1402	described	describe	I-NP	VBN	O	3	NMOD	O
O	O	1403	1413	conditions	condition	I-NP	NNS	O	0	ROOT	O
O	O	1414	1419	which	which	B-NP	WDT	O	3	NMOD	O
O	O	1420	1429	inhibited	inhibit	B-VP	VBD	O	4	SBAR	O
O	O	1430	1432	or	or	I-VP	CC	O	5	VMOD	O
O	O	1433	1442	prevented	prevent	I-VP	VBD	O	5	VMOD	O
O	O	1443	1446	the	the	B-NP	DT	O	9	NMOD	O
O	O	1447	1457	activation	activation	I-NP	NN	O	5	VMOD	O
O	O	1458	1460	of	of	B-PP	IN	O	9	NMOD	O
O	O	1461	1464	the	the	B-NP	DT	O	17	NMOD	O
T6	B-Protein	1465	1467	IL	IL	I-NP	NN	B-protein	17	NMOD	B-protein
T6	I-Protein	1467	1468	-	-	B-NP	HYPH	I-protein	17	NMOD	I-protein
T6	I-Protein	1468	1471	1RI	1RI	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	1471	1472	-	-	O	HYPH	I-protein	17	NMOD	I-protein
O	O	1472	1482	associated	associate	B-NP	VBN	I-protein	17	NMOD	I-protein
O	O	1483	1489	kinase	kinase	I-NP	NN	I-protein	10	PMOD	I-protein
O	O	1490	1499	similarly	similarly	B-ADVP	RB	O	5	VMOD	O
O	O	1500	1508	impaired	impair	B-VP	VBD	O	5	VMOD	O
O	O	1509	1512	the	the	B-NP	DT	O	21	NMOD	O
O	O	1513	1523	activation	activation	I-NP	NN	O	19	OBJ	O
O	O	1524	1526	of	of	B-PP	IN	O	21	NMOD	O
T14	B-Entity	1527	1529	NF	NF	B-NP	NN	B-protein	26	NMOD	B-protein
T14	I-Entity	1529	1530	-	-	B-NP	HYPH	I-protein	26	NMOD	I-protein
T14	I-Entity	1530	1535	kappa	kappa	I-NP	NN	I-protein	26	NMOD	I-protein
T14	I-Entity	1536	1537	B	B	I-NP	NN	I-protein	22	PMOD	I-protein
O	O	1538	1540	in	in	B-PP	IN	O	21	NMOD	O
O	O	1541	1544	EL4	EL4	B-NP	NN	B-cell_line	29	NMOD	B-cell_line
O	O	1545	1550	cells	cell	I-NP	NNS	I-cell_line	27	PMOD	I-cell_line
O	O	1550	1551	.	.	O	.	O	3	P	O

O	O	1552	1556	From	From	B-PP	IN	O	5	VMOD	O
O	O	1557	1562	these	these	B-NP	DT	O	3	NMOD	O
O	O	1563	1575	observations	observation	I-NP	NNS	O	1	PMOD	O
O	O	1576	1578	we	we	B-NP	PRP	O	5	SUB	O
O	O	1579	1587	conclude	conclude	B-VP	VBP	O	0	ROOT	O
O	O	1588	1592	that	that	B-SBAR	IN	O	30	DEP	O
O	O	1593	1597	free	free	B-NP	JJ	O	8	NMOD	O
O	O	1598	1604	thiols	thiol	I-NP	NNS	O	15	SUB	O
O	O	1605	1607	in	in	B-PP	IN	O	8	NMOD	O
O	O	1608	1611	the	the	B-NP	DT	O	14	NMOD	O
T7	B-Protein	1612	1614	IL	IL	I-NP	NN	B-protein	14	NMOD	B-protein
T7	I-Protein	1614	1615	-	-	B-NP	HYPH	I-protein	14	NMOD	I-protein
T7	I-Protein	1615	1618	1RI	1RI	I-NP	NN	I-protein	14	NMOD	I-protein
T15	B-Entity	1619	1626	complex	complex	I-NP	NN	I-protein	9	PMOD	I-protein
O	O	1627	1630	are	be	B-VP	VBP	O	6	SBAR	O
O	O	1631	1640	essential	essential	B-ADJP	JJ	O	15	PRD	O
O	O	1641	1644	for	for	B-PP	IN	O	16	AMOD	O
O	O	1645	1648	the	the	B-NP	DT	O	19	NMOD	O
O	O	1649	1659	activation	activation	I-NP	NN	O	17	PMOD	O
O	O	1660	1662	of	of	B-PP	IN	O	19	NMOD	O
O	O	1663	1666	the	the	B-NP	DT	O	28	NMOD	O
T8	B-Protein	1667	1669	IL	IL	I-NP	NN	B-protein	28	NMOD	B-protein
T8	I-Protein	1669	1670	-	-	B-NP	HYPH	I-protein	28	NMOD	I-protein
T8	I-Protein	1670	1673	1RI	1RI	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	1673	1674	-	-	O	HYPH	I-protein	28	NMOD	I-protein
O	O	1674	1684	associated	associate	B-NP	VBN	I-protein	28	NMOD	I-protein
O	O	1685	1692	protein	protein	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	1693	1699	kinase	kinase	I-NP	NN	I-protein	20	PMOD	I-protein
O	O	1700	1703	and	and	O	CC	O	30	DEP	O
O	O	1704	1708	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	1709	1713	this	this	B-NP	DT	O	32	NMOD	O
O	O	1714	1721	process	process	I-NP	NN	O	33	SUB	O
O	O	1722	1724	is	be	B-VP	VBZ	O	30	SBAR	O
O	O	1725	1734	mandatory	mandatory	B-ADJP	JJ	O	33	PRD	O
O	O	1735	1738	for	for	B-PP	IN	O	34	AMOD	O
O	O	1739	1741	IL	IL	B-NP	NN	B-protein	39	NMOD	B-protein
O	O	1741	1742	-	-	B-NP	HYPH	I-protein	39	NMOD	I-protein
O	O	1742	1743	1	1	I-NP	CD	I-protein	39	NMOD	I-protein
O	O	1744	1753	signaling	signaling	I-NP	NN	O	35	PMOD	O
O	O	1754	1761	leading	lead	B-VP	VBG	O	39	NMOD	O
O	O	1762	1764	to	to	B-PP	TO	O	40	VMOD	O
T16	B-Entity	1765	1767	NF	NF	B-NP	NN	B-protein	46	NMOD	B-protein
T16	I-Entity	1767	1768	-	-	I-NP	HYPH	I-protein	46	NMOD	I-protein
T16	I-Entity	1768	1773	kappa	kappa	I-NP	NN	I-protein	46	NMOD	I-protein
T16	I-Entity	1774	1775	B	B	I-NP	NN	I-protein	46	NMOD	I-protein
O	O	1776	1786	activation	activation	I-NP	NN	O	41	PMOD	O
O	O	1786	1787	.	.	O	.	O	5	P	O
